医院手术量对上尿路尿路上皮癌根治性肾输尿管切除术短期和长期结局的影响
基于美国国家癌症数据库2004至2016年数据,纳入37,479例接受根治性肾输尿管切除术的上尿路尿路上皮癌患者,按医院年均手术量三分位分组,高容量定义为每年6例及以上。研究发现高容量医院患者的围手术期生存(30天和90天死亡率)及长期总生存均更优,多因素分析显示高容量中心与生存风险改善相关,剔除术后90天内死亡患者后长期生存关系仍一致。
要点
- 高容量医院(每年≥6例)的围手术期生存和长期总生存均优于低容量医院。
- 多因素分析显示高容量中心治疗与生存风险改善独立相关。
- 剔除术后90天内死亡患者后,高容量与长期生存的关系仍一致。
核心结论
- 高容量医院治疗不仅与围手术期结局改善相关,也与长期总生存改善相关。
- 机制可能涉及多因素,包括外科医生手术量和辅助支持服务均起关键作用。
研究设计与样本
- 回顾性队列研究,查询美国国家癌症数据库2004至2016年所有接受根治性肾输尿管切除术的上尿路尿路上皮癌病例。
- 共识别37,479例手术,分布于1,290家医院。
- 医院年均手术量按三分位分层,高容量定义为每年6例及以上,低容量为每年少于6例。
主要发现
- 低容量与高容量中心患者的基线健康状况和肿瘤分期无差异。
- 高容量中心患者的围手术期生存(30天和90天死亡率)和长期总生存均改善。
- 多因素生存分析中,高容量中心治疗与生存风险改善相关。
- 剔除术后90天内死亡患者后的里程碑分析中,高容量与长期生存的关系仍一致。
临床怎么用
- 对于上尿路尿路上皮癌需行根治性肾输尿管切除术的患者,可考虑转诊至高容量医院以改善短期和长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine the effect of hospital volume on short and long-term outcomes for radical nephroureterectomy (RNUx). Upper tract urothelial carcinoma is a rare malignancy that few surgeons have experience with. The hospital volume-outcome relationship has been well established for other cancers but not RNUx. METHODS: The National Cancer Database was queried for all cases of upper tract urothelial carcinoma that underwent RNUx from 2004 to 2016. Average annual hospital volume for radical nephroureterectomy was stratified into tertiles. The upper tertile, defined as 6 or more RNUx per year, was considered high volume while low volume was less than 6 RNUx per year. Kaplan-Meier and Cox proportional hazards regression were used to identify independent predictors of overall survival, and logistic regression was used to identify predictors of perioperative outcomes. RESULTS: We identified 37,479 RNUx performed across 1290 hospitals. There were no differences in baseline health or cancer staging between patients who presented at low- versus high-volume centers. Both peri-operative survival (30- and 90-day mortality) and long-term overall survival were improved in patients treated at high-volume centers. On multivariable survival analysis, treatment at a high-volume center was associated with improved hazards of survival. This relationship for long-term survival remained consistent on landmark analysis where patients who died within 90 days of surgery were removed. CONCLUSIONS: Treatment at a high-volume hospital was associated not only with improved short-term perioperative outcomes but also with improved overall long-term survival. The mechanism behind this is likely multifactorial with surgeon volume, and ancillary support services all playing critical roles.
引用
- Sui W, Wallis CJD, Luckenbaugh AN, et al. The Impact of Hospital Volume on Short-term and Long-term Outcomes for Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Urology. 2020. PMID: 32891638. doi:10.1016/j.urology.2020.07.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。